Keywords: CimaVax-EGF, Vaccine, Lung cancer, Cuba, CIM
CimaVax-EGF, the first vaccine against lung cancer, debuts in Cuba
Article | 08 September 2011
Following regulatory approval earlier this year, Cuban medical authorities have launched the world's first therapeutic vaccine against lung cancer, according ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
